Book contents
- Frontmatter
- Preface
- Contents
- CME Information
- Objectives
- Chapter 1 Neurobiology of Depression
- Chapter 2 Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
- Chapter 3 Norepinephrine and Dopamine Reuptake Inhibitors (NDRIs) and Selective Norepinephrine Reuptake Inhibitors (NRIs)
- Chapter 4 Alpha 2 Antagonists as Serotonin and Norepinephrine Disinhibitors (SNDIs) and Serotonin Antagonist/Reuptake Inhibitors (SARIs)
- Chapter 5 Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs)
- Chapter 6 Building a Treatment Plan with Novel Treatment and Augmentation Options For Depression
- Chapter 7 Depression in Women: Treating Symptoms Throughout the Life Span
- Chapter 8 Pharmacokinetics and Algorithms to Treat Depression
- Summary
- Abbreviations and Symbols
- Suggested Readings
- Index
- CME: Posttest
Chapter 2 - Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
Published online by Cambridge University Press: 19 October 2021
- Frontmatter
- Preface
- Contents
- CME Information
- Objectives
- Chapter 1 Neurobiology of Depression
- Chapter 2 Selective Serotonin Reuptake Inhibitors (SSRIs) and Serotonin Norepinephrine Reuptake Inhibitors (SNRIs)
- Chapter 3 Norepinephrine and Dopamine Reuptake Inhibitors (NDRIs) and Selective Norepinephrine Reuptake Inhibitors (NRIs)
- Chapter 4 Alpha 2 Antagonists as Serotonin and Norepinephrine Disinhibitors (SNDIs) and Serotonin Antagonist/Reuptake Inhibitors (SARIs)
- Chapter 5 Monoamine Oxidase Inhibitors (MAOIs) and Tricyclic Antidepressants (TCAs)
- Chapter 6 Building a Treatment Plan with Novel Treatment and Augmentation Options For Depression
- Chapter 7 Depression in Women: Treating Symptoms Throughout the Life Span
- Chapter 8 Pharmacokinetics and Algorithms to Treat Depression
- Summary
- Abbreviations and Symbols
- Suggested Readings
- Index
- CME: Posttest
Summary
This chapter reviews some of the most commonly used first-line antidepressant drug options, the selective serotonin reuptake inhibitors (SSRIs) and serotonin norepinephrine reuptake inhibitors (SNRIs). For patients who do not completely remit on an SSRI or SNRI, oftentimes augmentation and/or combinations are introduced or the patient is switched to a second-line treatment. This concept is developed in further detail in later chapters. Here, each of the six drugs in the SSRI class and each of the four drugs in the SNRI class is reviewed.
- Type
- Chapter
- Information
- Stahl's Illustrated Antidepressants , pp. 41 - 70Publisher: Cambridge University PressPrint publication year: 2009